Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
23.50    0.00 (0.00%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £11.19m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Major Programme Update

3 Dec 2021 11:20

RNS Number : 5355U
Pennant International Group PLC
03 December 2021
 

FOR IMMEDIATE RELEASE

 

PENNANT INTERNATIONAL GROUP PLC

Major Programme Update

 

 

Pennant International Group plc (AIM:PEN)("Pennant", the "Group" or "Company"), a leading global provider of training technology and integrated product support solutions, provides the following pipeline update.

 

The Group was 'down-selected' for a major UK defence programme in August 2018 which was, at the time, anticipated to be contracted in that year.

 

The opportunity has since been subject to protracted negotiations between Pennant's customer and the Ministry of Defence and Pennant itself. This lengthy process has coincided with the Covid-19 pandemic, and with matters being paused for a time pending completion of the UK's 'Integrated Review of Security, Defence, Development and Foreign Policy'. At all points, the timing, scope and value of any contract award has been subject to contract.

 

With negotiations now believed to be drawing to a close, the Company has received written notification from the Ministry of Defence that Pennant's scope of supply will not be as substantial as originally contemplated. The Group's proposal in respect of certain items continues into final negotiation and the directors are increasingly confident that a contract (with a potential value now believed to be circa £9 million) will be secured in the first quarter of 2022.

 

Phil Walker, Group CEO, commented: "Given the length of time since the initial 'down-selection', our budgeting for the next three years had not assumed award of the full scope, and a contract worth in the region of £9 million, if awarded, will be a material win for us and substantially underpin our financial expectations for next year."

 

 

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director

+44 (0) 1452 714 914

WH Ireland Limited (Nomad and Broker)

www.whirelandcb.com

Mike Coe

Sarah Mather

+44 (0) 20 7220 1666

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDTJBBTMTBMBPB
Date   Source Headline
15th Aug 20168:20 amRNSDirector/PDMR Shareholding
15th Aug 20167:00 amRNSPlacing of £3.56m
19th Jul 20167:00 amRNSRecord Order Book drives expansion of premises
15th Jul 20169:30 amRNSHoldings in Company
14th Jul 201610:55 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSDirector Dealing
20th Jun 201612:05 pmRNSGrant of Options
16th Jun 20167:00 amRNSNew Contract Award and Trading Update
1st Jun 20167:14 amRNSNew Contract Awards worth in excess of £13 million
18th May 201612:00 pmRNSDirectorate Change
20th Apr 201611:17 amRNSResult of AGM and GM
19th Apr 20167:00 amRNSDirectorate Change
23rd Mar 20167:00 amRNSDocuments available on the Company's website
7th Mar 20167:00 amRNS2015 Final Results
3rd Mar 201611:00 amRNSDirectorate Change
5th Feb 20167:00 amRNSNew Contract Award & Notice of 2015 Final Results
11th Dec 20157:00 amRNSTrading Update
17th Nov 20157:00 amRNSDirectorate Change
19th Oct 20151:40 pmRNSDirector/PDMR Shareholding
5th Oct 20157:00 amRNSDirector Incentivisation
28th Sep 20157:00 amRNSNew £7million Contract Award
28th Sep 20157:00 amRNS2015 Interim Results
18th Sep 201512:00 pmRNSNotice of Results
26th Aug 20152:47 pmRNSHolding(s) in Company
14th Apr 201511:12 amRNSResult of AGM and GM
8th Apr 20152:30 pmRNSDirector/PDMR Shareholding
17th Mar 201512:00 pmRNSDocuments available on the Company's website
17th Mar 20159:55 amRNSDocuments available on the Company's website
17th Mar 20157:00 amRNS2014 Final Results
6th Mar 20157:00 amRNSNotice of Final Results
22nd Jan 20157:00 amRNSPre-close Trading Update
10th Nov 201412:00 pmRNSTransaction in Own Shares
22nd Sep 20147:00 amRNSDirectorate Change
17th Sep 20147:00 amRNSContract win
8th Sep 20147:00 amRNSHalf Yearly Report
1st Sep 201411:35 amRNSNotice of Results
15th Jul 20144:29 pmRNSDirector/PDMR Shareholding
24th Jun 20144:36 pmRNSDirector Dealing
6th Jun 20145:17 pmRNSDirector/PDMR Shareholding
29th Apr 20144:20 pmRNSDirector Incentivisation
10th Apr 20143:39 pmRNSResult of Meeting
12th Mar 20147:00 amRNSDirectorate Change
10th Mar 20147:00 amRNSFinal Results
10th Feb 20143:45 pmRNSHolding(s) in Company
3rd Feb 20142:14 pmRNSHolding(s) in Company
3rd Feb 20142:00 pmRNSHolding(s) in Company
9th Dec 20134:15 pmRNSHolding(s) in Company
14th Nov 201311:10 amRNSNotification of Major Interest of Shares
21st Oct 201311:03 amRNSDirector/PDMR Shareholding
5th Aug 20137:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.